Avianca Cargo Secures Pharma Certification in Spain

Avianca Cargo has secured Good Distribution Practice (GDP) Pharma certification for its Madrid and Barcelona operations, enhancing its capacity for pharmaceutical and healthcare cargo across Europe. This accreditation positions the airline to expand specialized transport services for temperature-sensitive medical products.

European Network Expansion Bolstered

body SGS issued the certification, confirming Avianca Cargo's adherence to World Health Organization guidelines for handling, storing, distributing, and transporting pharmaceutical products. This ensures the quality and integrity of these goods throughout the supply chain. Avianca Cargo becomes the first airline in the Americas to achieve GDP Pharma certification for pharmaceutical handling within its European network.

This new accreditation complements the carrier's existing IATA This new accreditation complements the carrier's existing IATA CEIV Pharma certification. Madrid and Barcelona function as key hubs for consolidating pharmaceutical shipments from across Europe, and the GDP Pharma status is expected to strengthen the airline's ability to offer controlled and traceable logistics solutions. Accelerated Certification Process Avianca Cargo completed the certification process in approximately six months, a significantly shorter timeframe compared to the typical 12 months required for such audits. Diogo Elias, CEO of Avianca Cargo, stated the certification reinforces the carrier's specialized pharmaceutical transport services. The airline, alongside Gollog, the logistics arm of the Abra Group, plans to extend GDP Pharma-certified operations. Strategic stations in London, Paris, and Lisbon are targeted for certification by 2027, further broadening the carrier's certified pharmaceutical logistics network. Global Macroeconomic Impact

Avianca Cargo

The global pharmaceutical logistics market, valued at approximately $100 billion in 2023, continues to expand. This growth is driven by increasing demand for temperature-controlled transport of complex biologics and vaccines. Enhanced certifications like GDP Pharma contribute to supply chain resilience, a critical factor for global health security and the timely distribution of essential medicines. This move by Avianca Cargo supports the broader trend of specialized logistics providers investing in compliance and infrastructure to meet stringent industry standards, potentially influencing trade flows of high-value medical goods between the Americas and Europe. Company and Industry Outlook For Avianca Cargo, this certification strengthens its competitive position in the lucrative pharmaceutical logistics sector, which commands higher margins due to its specialized requirements. The ability to offer verified compliant services in key European hubs could attract new clients and increase market share, particularly for high-value, temperature-sensitive products. Within the wider air cargo industry, this development highlights a growing emphasis on specialized certifications and compliance, pushing other carriers to invest in similar standards to remain competitive in niche markets. The planned expansion to additional European cities by 2027 indicates a strategic commitment to this segment, potentially setting a benchmark for regional pharmaceutical air freight.